Wearable injectors are compact, portable self-injection devices specifically designed to enable subcutaneous delivery of substantial amounts of drugs, producing a sustained therapeutic effect. These innovative systems offer numerous dosing options (basal, bolus or continuous), improving patient adherence and efficacy of treatments.
The financial opportunity within the wearable injectors market has been analyzed across the following segments:
§ Type of Device
- Patch Pumps / Injectors
- Infusion Pumps / Injectors
§ Usability
- Disposable
- Reusable
§ Therapeutic Area
- Autoimmune Disorders
- Cardiovascular Disorders
- Metabolic Disorders
- Neurological Disorders
- Oncological Disorders
- Other Disorders
§ Key Geographical Regions
- North America
- Europe
- Asia
- Latin America
§ Middle East and North Africa
The “Wearable Injectors Market 2023-2035” report features the following companies, which we identified to be key players in this domain:
§ CCBio
§ CeQur
§ Debiotech
§ Elcam Drug Delivery Devices
§ Eli Lilly
§ Enable Injections
§ Gerresheimer
§ Insulet
§ Medtronic
§ Medtrum Technologies
§ Pharmasense
§ Roche
§ Sonceboz
§ SOOIL Development
§ Weibel CDS
§ West Pharmaceuticals
Table of Contents
1. PREFACE
2. RESEARCH METHODOLOGY
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
4. EXECUTIVE SUMMARY
5. INTRODUCTION
6. LARGE VOLUME WEARABLE INJECTORS FOR NON-INSULIN DRUGS: CURRENT MARKET LANDSCAPE
7. LARGE VOLUME DRUG DEVICE COMBINATIONS FOR NON-INSULIN DRUGS: CURRENT MARKET LANDSCAPE
8. LARGE VOLUME WEARABLE INJECTORS FOR INSULIN DRUGS: CURRENT MARKET LANDSCAPE
9. PRODUCT COMPETITIVENESS ANALYSIS
10. LARGE VOLUME WEARABLE INJECTOR DEVELOPERS: COMPANY PROFILES
11. DRUG-DEVICE COMBINATIONS: DEVICE PROFILES
12. PARTNERSHIPS AND COLLABORATIONS
13. KEY ACQUISITION TARGETS
14. PATENT ANALYSIS
15. LARGE VOLUME WEARABLE INJECTORS: LIKELY DRUG CANDIDATES
16. CLINICAL TRIAL ANALYSIS
17. FUNDING AND INVESTMENT ANALYSIS
18. CASE STUDY: ROLE OF CONTRACT MANUFACTURING ORGANIZATIONS IN DEVICE DEVELOPMENT SUPPLY CHAIN
19. REGULATORY AND REIMBURSEMENT LANDSCAPE FOR MEDICAL DEVICES
20. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
21. MARKET SIZING AND OPPORTUNITY ANALYSIS FOR LARGE VOLUME WEARABLE INJECTORS FOR NON-INSULIN DRUGS
22. MARKET SIZING AND OPPORTUNITY ANALYSIS FOR LARGE VOLUME WEARABLE INJECTORS FOR INSULIN
23. SWOT ANALYSIS
24. CONCLUDING REMARKS
25. EXECUTIVE INSIGHTS
26. APPENDIX 1: TABULATED DATA
27. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/large-volume-wearable-injectors/238.html
Learn from experts: do you know about these emerging industry trends?
Novel Spectrometry Platforms: Key Advancements
Quantum Computing in Drug Discovery: Unleashing the Power
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
English